Ditch the VC: Alternative Funding Options for Biotech Startups
Getting money for a biotech startup can be a daunting task. Venture capital is not…
04/08/2021 - 9 minutes
Venture capital
Three Lessons an Investor Can Learn from Biotech Entrepreneurs
Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing…
07/07/2021 - 7 minutes
Biotech Investment Firms Intensify Funding Spree After 2020 Surge
Two big closings last month by Ysios Capital in Spain and Abingworth in the UK…
03/06/2021 - 6 minutes
Advice for my Younger Self: How to Be a VC in Life Sciences
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was…
08/03/2021 - 5 minutes
Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur
There is usually a big disparity between investors and entrepreneurs regarding the valuation of an…
26/08/2020 - 7 minutes
How Are Biotech VC Investments Changing with Covid-19?
Covid-19 has been dominating the news for weeks on end, but what impact is the…
04/05/2020 - 8 minutes
How Investors Can Prepare for the Digitization of Biotech
For a few decades, the worlds of biotech and digital technology have been on separate…
06/04/2020 - 6 minutes
Why European Biotechs Should Look to China for Investment
Traditionally European biotechs have looked to the US for additional investment, but changes in the…
11/02/2020 - 8 minutes
How to Make Healthcare Investments Accessible to the Public?
Early-stage investments in the healthcare sector are often dominated by public money, which is directly…
11/11/2019 - 7 minutes
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage…
17/10/2019 - 2 minutes
Wellington Partners Raises €210M to Invest in European Life Sciences
VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science…
31/07/2019 - 3 minutes
Update: Fund for Late-Stage European Biotechs Closes Final Round With €120M
Update (25/06/2019): The Luxembourg-based investor Vesalius Biocapital III has completed the final closing of a…
25/06/2019 - 3 minutes
